# Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB123667 in Healthy Male Participants

> **NCT07218744** · PHASE1 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 9 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** INCB123667

## Key facts

- **NCT ID:** NCT07218744
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-11-13
- **Primary completion:** 2025-12-10
- **Final completion:** 2025-12-10
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07218744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07218744, "Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB123667 in Healthy Male Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07218744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*